Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of an LTB4 antagonist for the treatment or prevention of diseases caused by increased expression of mucin genes

Use of an LTB4 antagonist for the treatment or prevention of diseases caused by increased expression of mucin genes

US Patent 6576669 · Granted Jun 10, 2003

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Spiral grooved thrust generator on turbine wheel back plate2025
Methods for treating pulmonary emphysema using substituted 2-Aza-bicyclo[2.2.1]h2019
Methods for treating pulmonary emphysema using substituted 2-Aza-bicyclo[2.2.1]h2017
Substituted bicyclic dihydropyrimidinones and their use as inhibitors of neutrop2017
Substituted bicyclic dihydropyrimidinones and their use as inhibitors of neutrop2016
Substituted bicyclic dihydropyrimidinones and their use as inhibitors of neutrop2016
Substituted bicyclic dihydropyrimidinones and their use as inhibitors of neutrop2016
Substituted oxetanes and their use as inhibitors of cathepsin C2016
Substituted dihydropyrimidinones and their use as inhibitors of neutrophil elast2016
Pyrazole compounds as CRTH2 antagonists2015
Heterocycle-substituted piperazino-dihydrothienopyrimidines2015
Method of using substituted 2-Aza-bicyclo[2.2.2]octane-3-carboxylic acid (benzyl2015